Erbi Biosystems, a part of MilliporeSigma

About Erbi Biosystems, a part of MilliporeSigma

Erbi Biosystems specializes in microfluidic bioprocess instrumentation that enhances the precision and efficiency of biological sample analysis. The technology addresses the challenges of scalability and reproducibility in bioprocessing, enabling researchers to achieve consistent results with reduced resource consumption.

```xml <problem> Traditional bioprocessing methods often suffer from scalability issues and inconsistent results due to manual handling and limited control over environmental parameters. This lack of reproducibility and efficiency hinders research and development efforts, particularly in areas requiring precise control over cellular environments. </problem> <solution> Erbi Biosystems offers microfluidic bioprocess instrumentation designed to enhance the precision, control, and scalability of biological sample analysis. Their technology enables researchers to achieve consistent and reproducible results by automating key bioprocessing steps and providing precise control over micro-environmental conditions. By minimizing manual intervention and optimizing resource utilization, Erbi Biosystems' solutions improve efficiency and reduce variability in bioprocessing workflows. The microfluidic approach allows for high-throughput experimentation with minimal sample volumes, accelerating research and development cycles. </solution> <features> - Automated microfluidic platform for precise control of cell culture parameters - Integrated sensors for real-time monitoring of temperature, pH, and dissolved oxygen - Scalable design for high-throughput experimentation and process optimization - User-friendly software interface for easy experiment setup and data analysis - Reduced reagent consumption and waste generation compared to traditional methods </features> <target_audience> The primary target audience includes researchers and scientists in biotechnology, pharmaceuticals, and academia who require precise and reproducible bioprocessing for cell culture, drug discovery, and other biological applications. </target_audience> ```

What does Erbi Biosystems, a part of MilliporeSigma do?

Erbi Biosystems specializes in microfluidic bioprocess instrumentation that enhances the precision and efficiency of biological sample analysis. The technology addresses the challenges of scalability and reproducibility in bioprocessing, enabling researchers to achieve consistent results with reduced resource consumption.

When was Erbi Biosystems, a part of MilliporeSigma founded?

Erbi Biosystems, a part of MilliporeSigma was founded in 2016.

Founded
2016
Employees
14 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Erbi Biosystems, a part of MilliporeSigma

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Erbi Biosystems specializes in microfluidic bioprocess instrumentation that enhances the precision and efficiency of biological sample analysis. The technology addresses the challenges of scalability and reproducibility in bioprocessing, enabling researchers to achieve consistent results with reduced resource consumption.

Funding

No funding information available.

Team (10+)

No team information available.

Company Description

Problem

Traditional bioprocessing methods often suffer from scalability issues and inconsistent results due to manual handling and limited control over environmental parameters. This lack of reproducibility and efficiency hinders research and development efforts, particularly in areas requiring precise control over cellular environments.

Solution

Erbi Biosystems offers microfluidic bioprocess instrumentation designed to enhance the precision, control, and scalability of biological sample analysis. Their technology enables researchers to achieve consistent and reproducible results by automating key bioprocessing steps and providing precise control over micro-environmental conditions. By minimizing manual intervention and optimizing resource utilization, Erbi Biosystems' solutions improve efficiency and reduce variability in bioprocessing workflows. The microfluidic approach allows for high-throughput experimentation with minimal sample volumes, accelerating research and development cycles.

Features

Automated microfluidic platform for precise control of cell culture parameters

Integrated sensors for real-time monitoring of temperature, pH, and dissolved oxygen

Scalable design for high-throughput experimentation and process optimization

User-friendly software interface for easy experiment setup and data analysis

Reduced reagent consumption and waste generation compared to traditional methods

Target Audience

The primary target audience includes researchers and scientists in biotechnology, pharmaceuticals, and academia who require precise and reproducible bioprocessing for cell culture, drug discovery, and other biological applications.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.